MRNA

Moderna, Inc.

Halal Rating :
Comfortable
Last Price $39.38 Last updated:
Market Cap $29.75b
7D Change -5.86%
1 Year Change -56.8%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Biological Products
  • Except Diagnostic Substances
Exchange NASDAQ
Next Earnings Date Oct. 31, 2024

Moderna, Inc. is a biotechnology company that focuses on developing messenger RNA (mRNA) therapeutics and vaccines. The company was founded in 2010 and gained significant prominence during the COVID-19 pandemic with its mRNA-based COVID-19 vaccine. Moderna's platform spans programs in infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases.

The company's primary business involves researching, developing, and commercializing medicines based on mRNA technology. Their product portfolio includes their COVID-19 vaccine (Spikevax) and various candidates in clinical trials for other conditions.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $1.86b $1.93b - - 0.00% 0.00%
June 30, 2024 $241.0m $1.6b - - 0.00% 0.00%
March 31, 2024 $167.0m $1.43b - - 0.00% 0.00%

Company Impact

Help us evaluate Moderna, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates